Official Podcast feed of MDedge Dermatology and Cutis Peer-to-Peer, part of the Medscape Professional Network. Weekly episodes include the latest in Dermatology News and peer-to-peer interviews with Doctor Vincent A. DeLeo, MD, and Dr. Candrice Heath, MD. Plus, resident discussions geared toward physicians-in-training. The information in this podcast is provided for informational and educational purposes only.
The COVID-19 pandemic has presented unique challenges for medical students applying to residency programs. In this episode, Candrice R. Heath, MD (@DrCandriceHeath), talks to Virginia Alvarado Jones, MD, MS (@GinaAlvaJones), and medical student Victoria Humphrey (@VictoriaSHumphrey) about their experience navigating the dermatology residency Match process during this application cycle. They provide tips and takeaways for the next group of applicants, including how to adapt to the virtual interview process and connect with mentors and fellow residents without regular in-person contact. Dr. Heath also talks to residency program director Ilana Rosman, MD (@ilanarosman), about how the past year has opened the door for much needed changes in the residency application process (begins at 28:50). “We had two pandemics this year, right? We have COVID, and we have racial injustice. And I think that's not new. That's obviously not new at all. But I think it really has come to the forefront. And I think those two things together have made all of us much more cognizant of how we go about the process of residency selection and application making sure that we can make it equitable, inclusive, and sustainable moving forward,” Dr. Rosman says. They also discuss a holistic approach to reviewing residency applicants and virtual mentorships. * * * Host: Candrice R. Heath, MD (Temple University Hospital, Philadelphia) Guests: Virginia Alvarado Jones, MD, MS (California Pacific Medical Center, San Francisco; University of Illinois at Chicago); Victoria Humphrey (University of Pittsburgh); Ilana Rosman, MD (Washington University, St. Louis) Disclosures: Dr. Heath, Dr. Jones, and Dr. Rosman, as well as Ms. Humphrey, report no conflicts of interest. Show notes by: Alicia Sonners, Melissa Sears * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgeDerm
5/6/21 • 54:29
Ethnic minorities and patients living in socioeconomically disadvantaged areas are disproportionately impacted by a growing national shortage of dermatologists. In this resident takeover, Sophie A. Greenberg, MD (Twitter: @sophiegreenberg; Instagram: @sophiegreenbergmd), talks to Soraya Azzawi, MD, about how dermatology residency can serve as an opportunity to address barriers to equitable care in these populations and enact change within the specialty: “There is a stark regional misdistribution of the dermatologic workforce, with specialists tending to concentrate in the urban areas, and more rural areas are largely underserved. And as we progress through residency and start thinking about the overall trajectory of our career, it's going to be important to consider how the imbalance of the dermatologic workforce will shape where we choose to practice and how that choice impacts vulnerable communities with the greatest unmet needs,” Dr. Azzawi explains. They discuss various systemic factors that limit care in vulnerable communities and highlight ways that dermatology residents can work to better understand and meet the needs of underserved patient populations. Article: https://www.mdedge.com/dermatology/article/238575/diversity-medicine/empowering-residents-address-socioeconomic-disparities Downloadable PDF: https://cdn.mdedge.com/files/s3fs-public/CT107003043_e.PDF * * * Host: Sophie A. Greenberg, MD (Columbia University Medical Center, New York) Guest: Soraya Azzawi, MD (University of Miami/Jackson Memorial Hospital) Disclosures: Dr. Greenberg and Dr. Azzawi report no conflict of interest. Show notes by: Alicia Sonners, Melissa Sears * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgeDerm
4/29/21 • 15:00
This week, Amber Atwater, MD, the immediate past president of the American Contact Dermatitis Society, reviews some highlights from the meeting, which was held in March. Dr. Atwater, associate professor of dermatology at Duke University, Durham, N.C., discusses the 2021 “Contact Allergen of the Year,” a chemical that has been linked to reactions associated with shin pads and is an emerging allergen that was the topic of a recent report in Dermatitis. Joining Dr. Atwater, Raina Bembry, MD, a dermatitis fellow at Duke University, provides the results of a study of shoe allergens she presented at the meeting. which found that about 20% of shoe allergens are not detected with the current screening series. Dr. Atwater and Dr. Bembry are first and second authors of this paper, respectively; other authors are members of the North American Contact Dermatitis Group. Dr. Atwater also reviews the results of a study on the potential role of expanded series patch testing in residual facial dermatitis in patients treated with dupilumab (which received the Gold Alexander A. Fisher Resident Award at the meeting), a study on patterns of contact allergy in Black and White patients in Philadelphia over 10 years (which received the Silver Fisher Resident Award), a study of contact dermatitis information on different social media sites, and results of NACDG patch test results from 2017 to 2018. Dr. Atwater disclosed receiving the Pfizer Independent Grant for Learning & Change and consulting for Henke. Dr. Bembry had no disclosures. References: https://www.mdedge.com/dermatology/article/237677/contact-dermatitis/contact-allergen-year-found-foam-shin-guards-footwear https://www.mdedge.com/dermatology/article/237834/contact-dermatitis/check-all-components-cases-suspected-shoe-allergy https://www.mdedge.com/dermatology/article/237899/contact-dermatitis/contact-dermatitis-content-varies-among-social-media * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com
4/22/21 • 20:24
Recent studies have highlighted poor representation of darker skin types in dermatology textbooks and online resources. Vincent A. DeLeo, MD, talks to Jules B. Lipoff, MD (@juleslipoff), about the general paucity of images of skin of color in learning resources as well as an overrepresentation of darker skin types in material about sexually transmitted infections. “We should be teaching our students and our residents. It shouldn’t be just a skin of color lecture. Skin of color should be through every lecture. We should be showing how everything presents in every skin type,” Dr. Lipoff notes. They also discuss the flaws in the Fitzpatrick skin type system. Article: https://www.mdedge.com/dermatology/article/236888/diversity-medicine/distribution-skin-type-diversity-photographs-aad Downloadable PDF: https://cdn.mdedge.com/files/s3fs-public/CT107003157.PDF * * * Host: Vincent A. DeLeo, MD (University of Southern California, Los Angeles) Guest: Jules B. Lipoff, MD (department of dermatology, University of Pennsylvania, Philadelphia) Disclosures: Dr. DeLeo is a consultant for Estée Lauder. Dr. Lipoff reports no conflict of interest. Show notes by: Allegra Sparta, Melissa Sears * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com
4/15/21 • 16:23
In 2019, the two CPT codes for skin biopsies were replaced with six new codes that specify biopsy technique and associated procedural complexity. Vincent A. DeLeo, MD, talks to medical student Sheena Desai and Rebecca I. Hartman, MD, MPH, about this CPT change and its effect on the frequency of shave versus punch biopsies in both private and academic practices. “The average dermatologist needs to be cognizant of the fact that changing reimbursements may hypothetically influence [the] provider’s decision on what biopsy type to perform,” Ms. Desai notes. They also explain how this data can be extrapolated at a national scale. Article: https://www.mdedge.com/dermatology/article/236840/practice-management/comparison-shave-and-punch-biopsy-utilization-among Downloadable PDF: https://cdn.mdedge.com/files/s3fs-public/CT107003151.PDF * * * Host: Vincent A. DeLeo, MD (University of Southern California, Los Angeles) Guests: Sheena Desai, BS (department of dermatology, Brigham and Women’s Hospital, Harvard Medical School, both in Boston); Rebecca I. Hartman, MD, MPH (department of dermatology, Brigham and Women’s Hospital, Harvard Medical School, and the department of dermatology, Jamaica Plain (Mass.) Veterans Affairs Medical Center) Disclosures: Dr. DeLeo is a consultant for Estée Lauder. Ms. Schwartzberg and Dr. Hartman report no conflict of interest. Show notes by: Allegra Sparta, Melissa Sears * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com
4/8/21 • 10:19
COVID-19 affects multiple organ systems, and skin manifestations are prevalent. Dr. Vincent DeLeo talks to medical student Lauren Schwartzberg and Ann Lin, DO, about both common and rare cutaneous presentations of COVID-19. “I think it’s important to look at the unexplained rashes a little differently now than ever before the COVID era ... a thorough history of COVID-19 exposures and perhaps even COVID-19 testing should be considered,” Ms. Schwartzberg notes. They also discuss differences in presentation seen in adult and pediatric patients. Article: https://www.mdedge.com/dermatology/article/235467/infectious-diseases/cutaneous-manifestations-covid-19 Downloadable PDF: https://cdn.mdedge.com/files/s3fs-public/CT107002090.PDF * * * Host: Vincent A. DeLeo, MD (University of Southern California, Los Angeles) Guests: Lauren Schwartzberg, OMS-IV (New York Institute of Technology College of Osteopathic Medicine, Old Westbury); Ann Lin, DO (department of dermatology, St. John’s Episcopal Hospital, Far Rockaway, N.Y.) Disclosures: Dr. DeLeo is a consultant for Estée Lauder. Ms. Schwartzberg and Dr. Lin report no conflict of interest. Show notes by: Allegra Sparta, Melissa Sears * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com
4/1/21 • 09:44
Recent surveys show that dermatologic examinations tend to neglect the genital area. In this resident takeover, Sophie A. Greenberg, MD (@sophiegreenberg), talks to Margaret Maria Cocks, MD, PhD (@Margaret_Cocks), about the lack of focus on the genital area in the total-body skin examination (TBSE), especially in female patients, and the paucity of training on genital examinations in residency. “While [melanoma] is rare, a lot of the time when genital melanomas are identified, they’re often found later and more aggressive stages ... partially that might be because this area is not routinely examined by any care provider,” Dr. Cocks notes. They also discuss practical tips for including the genital area in the TBSE while focusing on patient comfort as well as diseases that may be overlooked by omitting the genitals in a TBSE. Article: https://www.mdedge.com/dermatology/article/236692/practice-management/genital-examination-dermatologic-practice?channel=28253 Downloadable PDF: https://cdn.mdedge.com/files/s3fs-public/CT107002029_e.pdf * * * Host: Sophie A. Greenberg, MD (department of dermatology, Columbia University Medical Center, New York) Guests: Margaret Maria Cocks, MD, PhD (department of dermatology, University of Utah, Salt Lake City) Disclosures: Dr. Greenberg and Dr. Cocks report no conflict of interest. Show notes by: Allegra Sparta, Melissa Sears * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgeDerm
3/25/21 • 22:44
Dr. Murad Alam, professor of dermatology and chief of cutaneous and aesthetic surgery in the department of dermatology at Northwestern University, Chicago, discusses recently released evidence-based recommendations on preventing and treating adverse events from injectable fillers. A recent paper outlines recommendations from an American Society for Dermatologic Surgery (ASDS) multidisciplinary task force. The paper was published in the February issue of Dermatologic Surgery (Dermatol Surg. 2021 Feb 1;47(2):214-26). Dr. Alam also provides an overview of a new patient safety database – the Cutaneous Procedures Adverse Events Reporting (CAPER) system -- a collaboration between Northwestern’s department of dermatology and the ASDS Association (ASDSA). Dr. Alam is a past ASDS president and current chair of the ASDSA’s Federal Affairs Work Group. He had no disclosures. References: ASDS issues first filler safety recommendations Dermatologic surgeons debut adverse event reporting database * * * You can find more of our podcasts at: http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgeDerm
3/18/21 • 20:16
Medical professionals play an important role in educating the public about COVID-19 vaccination. In this episode, Dr. Candrice Heath (@DrCandriceHeath) talks to A. Shadi Kourosh, MD, MPH (@AskDermMD), and Maritza I. Perez, MD, about the impact of the COVID-19 vaccine on dermatology practices. Dr. Kourosh explains how dermatologists can counsel patients on timing of cosmetic procedures such as fillers in relationship to vaccination. They also discuss skin reactions. “I think a take-home message is that there are a variety of different [skin] reactions but that we know what they are and that they’re manageable. So the most important thing is that everyone go ahead and get vaccinated – that we as a medical community need to send our patients a message that these reactions are not in any way an obstacle to vaccination,” Dr. Kourosh advises. Dr. Kourosh and Dr. Perez also discuss how in-office procedures have changed as more patients and physicians are vaccinated. * * * Host: Candrice R. Heath, MD (Temple University Hospital, Philadelphia) Guests: A. Shadi Kourosh, MD, MPH (Harvard Medical School, Boston; Massachusetts General Hospital, Boston); Maritza I. Perez, MD (University of Connecticut, Farmington; Icahn School of Medicine at Mount Sinai, New York) Disclosures: Dr. Heath reports no conflict of interest. Dr. Karoush reports no conflict of interest. Dr. Perez reports no conflict of interest. Show notes by: Alicia Sonners, Melissa Sears * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgeDerm
3/11/21 • 28:40
Before the COVID-19 pandemic, telemedicine largely was underutilized in dermatology. Vincent A. DeLeo, MD, talks to George Han, MD, PhD, about the progression of the reimbursement process and the roadblocks encountered with the expansion of telemedicine. “To me, telemedicine really represents the opportunity to make a dent in access to care ... expanding our access to care, especially in underserved areas in places where a lot of people have barriers, people of lower socioeconomic status, skin of color ... there’s a lot of populations out there where we’re just not able to get the level of coverage and access to dermatologic care that we want,” Dr. Han notes. They also discuss the emergence of direct-to-consumer telemedicine services and how dermatology practices can compete. Article: https://www.mdedge.com/dermatology/article/235459/infectious-diseases/reimbursement-teledermatology-during-covid-19-public Downloadable PDF: https://cdn.mdedge.com/files/s3fs-public/CT107002061.PDF * * * Host: Vincent A. DeLeo, MD (University of Southern California, Los Angeles) Guest: George Han, MD, PhD (Icahn School of Medicine at Mount Sinai, New York) Disclosures: Dr. DeLeo is a consultant for Estée Lauder. Dr. Han reports no conflict of interest. Show notes by: Allegra Sparta, Melissa Sears * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com
3/4/21 • 19:21
To truly increase diversity in dermatology, students of color need to be encouraged that dermatology is achievable. In this resident takeover, Sophie A. Greenberg, MD (@sophiegreenberg), talks to Nicole A. Negbenebor, MD (Instagram: @naijalatte), about her personal experience navigating dermatology residency as an applicant of color. “Dermatology is such a wonderful field and I feel that it has had the ability to impact so many different people, different socioeconomic statuses, different backgrounds, but unfortunately the workforce does not reflect the population sometimes that they’re serving,” Dr. Negbenebor notes. They also discuss the importance of mentorship and networking opportunities, and Dr. Negbenebor offers advice on the dermatology residency application process. Article: https://www.mdedge.com/dermatology/article/235130/diversity-medicine/advice-applying-dermatology-applicant-color-keep-going?channel=64 Downloadable PDF: https://cdn.mdedge.com/files/s3fs-public/CT107001015_e.PDF * * * Host: Sophie A. Greenberg, MD (department of dermatology, Columbia University Medical Center, New York) Guests: Nicole A. Negbenebor, MD (department of dermatology, Brown University, Providence, R.I.) Disclosures: Dr. Greenberg and Dr. Negbenebor report no conflict of interest. Show notes by: Allegra Sparta, Melissa Sears * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgeDerm
2/25/21 • 12:39
Lorenzo Norris, MD, host of MDedge Psychcast, talks with Scott A. Norton, MD, MPH, MSc, and John Koo, MD, about delusions of infestation, weighing in on the diagnosis and management of patients with this challenging disorder, and more. Dr. Norton is a dermatologist and preventive medicine specialist at the Uniformed Services University of the Health Sciences in Bethesda, Md. Dr. Koo is professor of dermatology at the University of California, San Francisco, and is a dermatologist and board-certified psychiatrist. Dr. Norton and Dr. Koo had no relevant disclosures. Reference Delusional infestation surges during COVID-19 pandemic
2/18/21 • 58:19
Mobile applications are useful to educate medical students and trainees; however, there is no objective method to assess their quality. Vincent A. DeLeo, MD, talks to Babar Rao, MD, about determining the usefulness and credibility of dermatology educational apps including factors such as affordability, accuracy, and ease of use. “I think we will be dependent on digital learning, so the only way to really move forward is to get involved. ... I think we have to get involved and make sure that what is available on these digital educational portals is also as relevant or as accurate as our printed material,” Dr. Rao notes. They also discuss the shortcomings found in such apps, such as conflicts of interest and glitches in software performance. Article: https://www.mdedge.com/dermatology/article/233009/aesthetic-dermatology/mobile-apps-professional-dermatology-education Downloadable PDF: https://cdn.mdedge.com/files/s3fs-public/CT106006321.PDF * * * Host: Vincent A. DeLeo, MD (University of Southern California, Los Angeles) Guest: Babar Rao, MD (Center for Dermatology, Robert Wood Johnson Medical School, New Brunswick, N.J., and the department of dermatology, Weill Cornell Medicine, New York) Disclosures: Dr. DeLeo is a consultant for Estée Lauder. Dr. Rao reports no conflict of interest. Show notes by: Allegra Sparta, Melissa Sears * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com
2/11/21 • 15:14
Transcript of this episode is avaiable at: https://www.medscape.com/viewarticle/946600?src= Access to dermatologic care in rural areas is a growing problem. Dr. Vincent DeLeo talks to Robert T. Brodell, MD; Cindy Firkins Smith, MD; and medical student Alexandra Streifel about the influence of rural clinical experiences during residency, which may increase the likelihood of trainees establishing a practice in these isolated areas. “Rural areas are tremendously underserved. [Patients] are waiting months to get appointments. And so if we can increase the number of rural dermatologists, it’s primarily good for patients,” Dr. Smith notes. They also discuss telemedicine and its role in rural dermatologic care. Article: https://www.mdedge.com/dermatology/article/234121/health-policy/rural-residency-curricula-potential-target-improved-access Downloadable PDF: https://cdn.mdedge.com/files/s3fs-public/CT107001054.PDF * * * Hosts: Vincent A. DeLeo, MD (University of Southern California, Los Angeles) Guests: Robert T. Brodell, MD (department of dermatology, University of Mississippi Medical Center, Jackson); Cindy Firkins Smith, MD (Carris Health, Willmar, Minn.); Alexandra Streifel, BA (University of North Dakota, Grand Forks) Disclosures: Dr. DeLeo is a consultant for Estée Lauder. Dr. Brodell, Dr. Smith, and Ms. Streifel report no conflict of interest. Show notes by: Allegra Sparta, Melissa Sears * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com
2/4/21 • 18:02
In the news: Dermatologist survey spotlights psoriasis care deficiencies in reproductive-age women Expert panel addresses gaps in acne guidelines * * * There is strong evidence for a relationship between diet and various skin conditions. In this resident takeover, Daniel R. Mazori, MD, talks to Sophie A. Greenberg, MD (@sophiegreenberg), about the role of diet in acne, psoriasis, and atopic dermatitis. Because patients and parents of pediatric patients often inquire about diet in relationship to atopic dermatitis, Dr. Greenberg offers a closer analysis of the data on this association. “A small minority of patients can experience flares of their atopic dermatitis due to food allergies. And this is usually non–IgE-mediated allergen exposure. ... But I do think it’s important to know that it’s really a small minority that their skin disease flares in relationship to their diet, so I usually counsel patients that it’s unlikely to be related to diet and I think it’s important to be prudent in considering who you refer to an allergist to have a work-up for food allergies.” Article: https://www.mdedge.com/dermatology/article/233485/atopic-dermatitis/diet-and-skin-primer?channel=64 Downloadable PDF: https://cdn.mdedge.com/files/s3fs-public/CT106005031_e.PDF * * * Hosts: Nick Andrews; Daniel R. Mazori, MD (State University of New York, Brooklyn) Guest: Sophie A. Greenberg, MD (department of dermatology, Columbia University Medical Center, New York) Disclosures: Dr. Mazori and Dr. Greenberg report no conflict of interest. Show notes by: Allegra Sparta, Melissa Sears * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgeDerm
1/28/21 • 15:37
In the news: Pityriasis rosea carries few risks for pregnant women Adjuvant nivolumab plus ipilimumab shows strong results in resected stage IV melanoma * * * Because psoriasis and atopic dermatitis (AD) can greatly affect quality of life in pediatric patients, the development of treatments with low-side effect profiles and less laboratory monitoring is essential. Vincent A. DeLeo, MD, talks to Amy S. Paller, MD, and Jennifer B. Scott, MD, about biologics approved for psoriasis and AD in the pediatric population. “Progressively, we’ve seen the newer biologics being more and more effective in both adults and in children, so we’re able to take some of the more effective ones and apply them to our children and adolescents with psoriasis ... We keep raising the bar in children as well as adults,” Dr. Paller reflects. They also discuss the advantages and pitfalls of biologics versus traditional systemic treatments as well as therapies on the horizon. Article: https://www.mdedge.com/dermatology/article/231217/atopic-dermatitis/biologics-pediatric-psoriasis-and-atopic-dermatitis Downloadable PDF: https://cdn.mdedge.com/files/s3fs-public/CT106005224.PDF * * * Hosts: Nick Andrews, Vincent A. DeLeo, MD (University of Southern California, Los Angeles) Guests: Amy S. Paller, MD (department of dermatology and the department of pediatrics, Northwestern University, Chicago) and Jennifer B. Scott, MD (department of dermatology, Northwestern University) Disclosures: Dr. DeLeo is a consultant for Estée Lauder. Dr. Paller has been an investigator and/or consultant for numerous companies. Dr. Scott reports no conflict of interest. Show notes by: Allegra Sparta, Melissa Sears * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgeDerm
1/21/21 • 20:25
In the news: Baseline body surface area may drive optimal baricitinib responses Avoiding atopic dermatitis triggers easier said than done * * * * * * * * * Psoriasis patients often have additional comorbidities that put them at higher risk for developing COVID-19. In this episode, Candrice R. Heath, MD (@DrCandriceHeath), talks to Mark G. Lebwohl, MD, about the benefits of continuing biologic therapies for psoriasis during the COVID-19 pandemic. They discuss findings from registry data in Italy and New York City and how the data have impacted the latest guidelines for treatment. “The [National Psoriasis Foundation COVID-19 Task Force] has come out with a recommendation that strongly encourages patients on biologics to take [the COVID-19] vaccination and to not interrupt your biologic therapy,” Dr. Lebwohl explains. They also discuss how dermatologists can counsel patients about the safety of biologics so they feel comfortable continuing treatment during the pandemic. * * * Hosts: Nick Andrews; Candrice R. Heath, MD (Temple University Hospital, Philadelphia) Guests: Mark G. Lebwohl, MD (Icahn School of Medicine at Mount Sinai, New York) Disclosures: Dr. Heath reports no conflict of interest. Dr. Lebwohl is an employee of Mount Sinai and has received research funds and consulted with numerous pharmaceutical companies. Show notes by: Alicia Sonners, Melissa Sears * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgeDerm
1/14/21 • 24:25
Dermatology News: Swedish registry study finds atopic dermatitis significantly associated with autoimmune diseases Guidance issued on COVID vaccine use in patients with dermal fillers * * * Dermatologic adverse events can present differently in patients with skin of color (SOC) than in White patients. In this episode, Candrice R. Heath, MD (@DrCandriceHeath), talks to Sarah J. Noor, MD, and medical student Dulce Barrios about how skin toxicities from systemic cancer therapies and radiation treatment manifest in SOC patients, particularly in the form of pigmentary changes. “We really need to understand the pathogenesis or etiology of this discoloration, because I think when this is the initial presenting feature, it’s possible … even though it looks more just like hyperpigmentation on the skin, that there is some underlying inflammatory process going on,” Dr. Noor explains. They also discuss barriers that limit participation of SOC patients in oncology clinical trials. Dr. Noor and Ms. Barrios’s poster from the Skin of Color Society (@SkinOfColor) Scientific Symposium won the Best Oral Presentation Advancing Skin of Color Dermatology “Facing the Future Award.” * * * Hosts: Nick Andrews; Candrice R. Heath, MD (Temple University Hospital, Philadelphia) Guests: Sarah J. Noor, MD (Memorial Sloan Kettering Cancer Center, New York); Dulce Barrios, MS (State University of New York, Syracuse) Disclosures: Dr. Heath reports no conflict of interest. Dr. Noor participated in an advisory board for Kyowa Kirin. Ms. Barrios reports no conflict of interest. Show notes by: Allegra Sparta, Alicia Sonners * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgeDerm
1/7/21 • 31:03
This year's top peer-to-peer interviews focus on diversity in residency training, the response to COVID-19 in academic dermatology, and tips for preparing for virtual residency interviews. 1. Diversity in residency training 2. Academic dermatology's response to COVID-19 3. Preparing for virtual residency interviews Email Dermatology Weekly at podcasts@mdedge.com
12/24/20 • 63:39
Dermatology News: Beware a pair of dermatologic emergencies in children: https://bit.ly/37mGA2d Preadolescent acne: Management from birth requires increasing vigilance: https://bit.ly/34mCWn0 * * * Managing vitiligo can be difficult for both patients and physicians. In this episode, guest host Seemal R. Desai, MD, (@SeemalRDesaiMD) talks to Pearl E. Grimes, MD, about how to better classify vitiligo disease status and parameters that impact treatment choice. “There are some aspects of classification that are really key from a therapeutic as well as a prognostic perspective. The things that I look at on a day-to-day basis when I workup any new patient [include asking], what type of vitiligo do you have? Is it nonsegmental or is it segmental? Is the patient stable or are they progressive? And then I look at the severity of disease,” Dr. Grimes explains. They discuss the importance of stabilizing vitiligo, particularly on the face, and highlight the psychosocial impact of the disease. Dr. Grimes also highlights the role of supplements and antioxidants such as vitamin D in vitiligo treatment. * * * Hosts: Seemal R. Desai, MD (Innovative Dermatology, Dallas, and the University of Texas Southwestern Medical Center, Dallas) Guests: Pearl E. Grimes, MD (Vitiligo & Pigmentation Institute of Southern California, Los Angeles) Disclosures: Dr. Desai reports no conflict of interest. Dr. Grimes has conducted clinical research and/or served as a consultant for Clinuvel Pharmaceuticals, Dermaforce, Johnson & Johnson, Incyte, LaserOptek, L’Oréal, Pfizer, Procter & Gamble, and VT Technologies. Show notes by: Alicia Sonners, Melissa Sears * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgeDerm
12/17/20 • 30:32
Dermatology News: International expert group agrees on redefining psoriasis severity https://bit.ly/3a6a7PJ ‘Impressive’ results with neoadjuvant T-VEC in advanced melanoma: https://bit.ly/39UEwA3 CDC shortens COVID-19 quarantine time to 10 or 7 days, with conditions: https://bit.ly/3qGIGSn * * * Procedural interventions in pediatric patients require special tools. Vincent A. DeLeo, MD, talks to Craig N. Burkhart, MD, MS, MPH, about dermatologic procedures in children, such as laser treatment of birthmarks or excisional mole removal. When considering general anesthesia use in children, Dr. Burkhart reflects that, “if [the patient is] a child that sits for a vaccination without a problem, they’re definitely ready to have minor surgery awake. If ... you have to pull them out from behind the bed, they’re definitely a child that is not ready.” They also discuss the importance of informed consent in teenaged patients. Article: https://www.mdedge.com/dermatology/article/231231/pediatrics/pediatric-procedural-dermatology Downloadable PDF: https://cdn.mdedge.com/files/s3fs-public/CT106005253.PDF * * * Hosts: Nick Andrews, Vincent A. DeLeo, MD (University of Southern California, Los Angeles) Guest: Craig N. Burkhart, MD, MS, MPH (department of dermatology, University of North Carolina at Chapel Hill, and Burkhart Pediatric & Adolescent Dermatology, Cary, N.C.) Disclosures: Dr. DeLeo is a consultant for Estée Lauder. Dr. Burkhart reports no conflict of interest. Show notes by: Allegra Sparta, Melissa Sears * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com
12/10/20 • 17:54
Dermatology News: Expanded indications likely for apremilast: https://bit.ly/3lx1zTZ Neoadjuvant immunotherapy combo produces high response rate in melanoma: https://bit.ly/33Dx0Wr Blood glucose on admission predicts COVID-19 severity in all: https://bit.ly/39yJjXS * * * Advances in noninvasive skin imaging present new opportunities for inclusion and equitable treatment of patients with skin of color. In this episode, Candrice R. Heath, MD (@DrCandriceHeath), talks to Josèe Smith and Steven Daveluy, MD, about the use of optical coherence tomography (OCT) to establish a baseline for all skin types can improve how dermatologists process pathology in the skin. They review various factors that influence OCT results and how results differ based on Fitzpatrick skin type, age, and level of sun exposure. They also highlight the benefits of noninvasive imaging versus biopsy in clinical practice. “[Even] though skin cancer is less common in skin of color, we know that melanoma and other types of skin cancer are usually diagnosed at later stages and more complicated stages, and so having earlier ways of detecting skin cancer in skin of color I think is really important for the future,” Ms. Smith explains. Ms. Smith and Dr. Daveluy’s poster from the Skin of Color Society (@SkinOfColor) Scientific Symposium won the Crowd Favorite award. * * * Hosts: Nick Andrews; Candrice R. Heath, MD (Temple University Hospital, Philadelphia, Pennsylvania) Guests: Josèe Smith, BS (Wayne State University, Detroit); Steven Daveluy, MD (Wayne State University and Wayne County Medical Society of Southeast Michigan, Detroit) Disclosures: Dr. Heath, Ms. Smith, and Dr. Daveluy report no conflicts of interest. Show notes by: Alicia Sonners, Melissa Sears * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgeDerm
12/3/20 • 32:09
Dermatology News: Merino wool clothing improves atopic dermatitis, studies find: https://bit.ly/3fFHQQI Tildrakizumab for psoriasis shows durable efficacy over 5 years: https://bit.ly/3l1Z0c9 AMA takes on vaccine misinformation, physician vaccines, racism: https://bit.ly/33ee0O2 * * * Nail unit squamous cell carcinoma (SCC) is difficult to diagnose or suspect clinically because of its tendency to present as nonspecific nail plate changes. The tumors usually are painless and asymptomatic, leading to a delay in diagnosis. In this resident takeover, Daniel R. Mazori, MD, talks to Mohammed Dany, MD, PhD, about nail unit SCC and the importance of early diagnosis to avoid local destruction and bone invasion. “Usually, any subungual lesion in an immunosuppressed individual, especially if it is chronic and nonhealing, would prompt a biopsy,” Dr. Dany explains. They also discuss other risk factors and potential causes for nail unit SCC, with a particular focus on human papillomavirus infection, as well as treatment options including surgery. Article: https://www.mdedge.com/dermatology/article/231900/hair-nails/nail-unit-squamous-cell-carcinoma-updates-diagnosis-surgical?channel=64 Downloadable PDF: https://cdn.mdedge.com/files/s3fs-public/CT106005011_e.PDF * * * Hosts: Nick Andrews; Daniel R. Mazori, MD (State University of New York, Brooklyn) Guests: Mohammed Dany, MD, PhD (Department of Dermatology, University of Pennsylvania, Philadelphia) Disclosures: Dr. Mazori and Dr. Dany report no conflict of interest. Show notes by: Allegra Sparta, Melissa Sears * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgeDerm
11/26/20 • 22:02
Dermatology News: Low threshold to biopsy atypical lesions may ID vulvar melanoma early, experts say https://www.mdedge.com/dermatology/article/231855/gynecologic-cancer/low-threshold-biopsy-atypical-lesions-may-id-vulvar Chronic inflammatory diseases vary widely in CHD risk https://www.mdedge.com/dermatology/article/231815/cad-atherosclerosis/chronic-inflammatory-diseases-vary-widely-chd-risk ‘Hospital at home’ increases COVID capacity in large study https://www.mdedge.com/dermatology/article/232113/coronavirus-updates/hospital-home-increases-covid-capacity-large-study The COVID-19 pandemic has brought many longstanding health disparities to the forefront, particularly within the field of dermatology. In this episode, Candrice R. Heath, MD (@DrCandriceHeath) talks to Susan C. Taylor, MD, and Lynn McKinley-Grant, MD, about the impact dermatologists can have in reducing health care barriers among skin of color populations. They emphasize the importance of race-concordant visits and reflect on ways to foster diversity, equity, and inclusion in the dermatology workforce, beginning at the training and residency levels. “[We know] that minority dermatologists serve in underserved communities, that they accept public insurance or no insurance at all. They care for patients with particularly poor health status and are really committed to caring for patients of their own race. So it behooves all of us to examine ... how we can make a change and increase racial ethnic diversity within the specialty of dermatology,” Dr. Taylor explains. They also highlight how organizations such as the American Academy of Dermatology and the Skin of Color Society, among others, are working to institute meaningful change within the specialty. * * * Hosts: Nick Andrews; Candrice R. Heath, MD (Temple University Hospital, Philadelphia) Guests: Susan C. Taylor, MD (University of Pennsylvania, Philadelphia); Lynn McKinley-Grant, MD (Howard University, Washington) Disclosures: Dr. Heath reports no conflict of interest. Dr. Taylor is vice president of the AAD. Dr. McKinley-Grant is president of the Skin of Color Society. Show notes by: Alicia Sonners, Melissa Sears * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgeDerm
11/19/20 • 43:25
Dermatology News: Who’s at risk for depression on isotretinoin?: https://bit.ly/32AioXp Topical tapinarof effective in pivotal psoriasis trials: https://bit.ly/3pma0o0 Methotrexate users need tuberculosis tests in high-TB areas: https://bit.ly/3f0DcMV * * * Keeping up with the literature on atopic dermatitis (AD) is a challenge, with eight new articles posted on PubMed a day in 2020. Vincent A. DeLeo, MD, talks to Lawrence F. Eichenfield, MD, about quality of life in pediatric AD patients and how the condition affects parents/guardians, particularly in the form of sleep disturbances. Dr. Eichenfield also discusses studies that explore the impact of bathing frequency on the severity of AD as well as notable treatment advances in topical and systemic therapies in recent years. Reflecting on future research, Dr. Eichenfield posited if “recognizing significant disease early and instituting our more aggressive therapies early, will that change the development of comorbidities and will that burn out the disease more quickly or get sustained remission or cure as compared to just waiting?” Article: https://bit.ly/3f0DrHP Downloadable PDF: https://bit.ly/3lzuUy1 * * * Hosts: Nick Andrews, Vincent A. DeLeo, MD (University of Southern California, Los Angeles) Guest: Lawrence F. Eichenfield, MD (division of pediatric dermatology, departments of dermatology and pediatrics, University of California, San Diego, and Rady Children’s Hospital, San Diego) Disclosures: Dr. DeLeo is a consultant for Estée Lauder. Dr. Eichenfield is an investigator for AbbVie, LEO Pharma, Pfizer, Regeneron, and Sanofi Genzyme. He also is a consultant for Almirall, Dermavant Sciences, Dermira, DS Biopharma, Eli Lilly, Forte Biopharma; Galderma Laboratories, Incyte, LEO Pharma, Novartis, Ortho Dermatologics, Otsuka Pharmaceutical, Pfizer, Regeneron Pharmaceuticals, and Sanofi Genzyme. Show notes by: Allegra Sparta, Melissa Sears * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com
11/12/20 • 27:29
Dermatology News: No lab monitoring needed in adolescents on dupilumab: https://bit.ly/34YAqV0 Birch bark derivative gel found effective for EB, in phase 3 study: https://bit.ly/385LFge Skin symptoms common in COVID-19 ‘long-haulers: https://bit.ly/385LFge * * * Peer-to-peer Underrepresented minority (URM) students often lack the resources needed to successfully navigate careers in medicine. In this episode, Candrice Heath, MD, (@DrCandriceHeath) talks to Alfredo Siller, MD, and Amit Pandya, MD, about the influence of social and cultural capital on a URM applicant’s competitiveness for dermatology residency programs. They discuss factors that impede diversification during the residency selection process and suggest potential solutions to promote equity among dermatology program applicants. “It is important when looking at residency candidates to value factors such as cultural competence, language skills, distance traveled, grit, having overcome adversity, and also look at the applicant and say: ‘Is this individual more likely to go work in an underserved community?’ Because that’s where our patients need us,” Dr. Siller explains. Dr. Siller’s poster from the Skin of Color Society (@SkinOfColor) Scientific Symposium won Best Poster for Advancing Skin of Color Dermatology "Facing the Future Award." * * * Hosts: Nick Andrews; Candrice R. Heath, MD (Temple University Hospital, Philadelphia) Guests: Alfredo Siller Jr, MD (Center for Clinical Studies, Webster, Texas); Amit G. Pandya, MD (University of Texas Southwestern Medical Center, Dallas; Palo Alto Foundation Medical Group, Mountain View, Calif.) Disclosures: Dr. Heath reports no conflict of interest. Dr. Siller reports no conflict of interest. Dr. Pandya is a consultant for Arcutis Biotherapeutics, AVITA Medical, Chromaderm, the Immune Tolerance Network, Incyte, Pfizer, Viela Bio, and Villaris Therapeutics. He also is an investigator for Aclaris Therapeutics, the Immune Tolerance Network, Incyte, and Pfizer. He also has stock options in Clarify Medical and Tara Medical Enterprise. Show notes by: Alicia Sonners, Melissa Sears * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgeDerm
11/5/20 • 33:50
Dermatology news: Data on potential risks of COVID-19 in psoriasis patients limited, but reassuring: https://bit.ly/3jwNc0Q Red hair in women linked to elevated CRP levels in Nurses’ Health Study: https://bit.ly/2HyJRSb Rinse and repeat? Mouthwash might mitigate COVID-19 spread: https://bit.ly/2HKjF6w * * * Dermatologists must feel comfortable and confident in diagnosing skin conditions in patients with skin of color, which begins during residency. In this resident takeover, Daniel R. Mazori, MD, and Nadine Shabeeb, MD, MPH, discuss how images of skin of color are greatly underrepresented in dermatology education resources, specifically textbooks and online resources. “We really rely on our textbooks for images and photographs of disease entities that we may not see that often clinically, and so if all of our patients are not represented in our resources and if we’re not seeing those patients in clinic, we’re really not ever going to be able to accurately learn and diagnose certain skin diseases,” Dr. Shabeeb explains. She also talks about her efforts to improve and strengthen the skin of color curriculum and provide antiracism resources within her residency program. Article: https://bit.ly/3kvBTHo PDF: https://bit.ly/35CfF0a * * * Hosts: Nick Andrews; Daniel R. Mazori, MD (State University of New York, Brooklyn) Guests: Nadine Shabeeb, MD, MPH (University of Wisconsin–Madison) Disclosures: Dr. Mazori and Dr. Shabeeb report no conflict of interest. Show notes by: Alicia Sonners, Melissa Sears * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgeDerm
10/29/20 • 36:00
Dermatology News: Non-Whites remain sorely underrepresented in phase 3 psoriasis trials (https://bit.ly/3jmv2ia) Women make progress in pediatric dermatology leadership (https://bit.ly/35nNdir) Survey: Doctors lonely, burned out in COVID-19 (https://bit.ly/3dKwhXg) * * * Psoriasis patients who are pregnant or those seeking a medication-free treatment may benefit from phototherapy. Vincent A. DeLeo, MD, talks to George Han, MD, PhD, and Jashin J. Wu, MD, about the joint guidelines from the American Academy of Dermatology and National Psoriasis Foundation for psoriasis treatment with phototherapy. They provide tips for getting patients started on phototherapy and discuss different devices for at-home or in-office use. While discussing avoidance of treatment pitfalls, Dr. Han notes that “documentation really is key when you’re doing phototherapy, and that’s one of the nice things about some of the newer phototherapy units. They’ll actually be linked up to a computer control that automatically keeps the treatment record.” Article: https://www.mdedge.com/dermatology/article/226940/psoriasis/translating-2019-aad-npf-guidelines-care-management-psoriasis Downloadable PDF: https://cdn.mdedge.com/files/s3fs-public/CT106002082.pdf * * * Hosts: Nick Andrews, Vincent A. DeLeo, MD (University of Southern California, Los Angeles) Guests: George Han, MD, PhD (Icahn School of Medicine at Mount Sinai, New York); Jashin J. Wu, MD (Dermatology Research and Education Foundation, Irvine, Calif.) Disclosures: Dr. DeLeo is a consultant for Estée Lauder. Dr. Han and Dr. Wu report conflicts of interest with numerous sources in industry. Show notes: Allegra Sparta, Melissa Sears * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com
10/22/20 • 26:47
In this week’s podcast, Dermatology News columnist Leslie S. Baumann, MD, interviews James J. Leyden, MD, emeritus professor of dermatology at the University of Pennsylvania, Philadelphia, about his significant research contributions in the field of dermatology, including finding the cure for diaper rash and the development of retinoids for acne and photoaging. Dr. Leyden also recounts his experience working with Albert Kligman, MD, at the University of Pennsylvania and how they changed the way the world treats acne with lots of contemplation, observation, perseverance, and a little luck. * * * 1. The interesting history of dermatologist-developed skin care (https://www.mdedge.com/dermatology/article/227534/aesthetic-dermatology/interesting-history-dermatologist-developed-skin?channel=27928) 2. More on the history of dermatologists and skin care (https://www.mdedge.com/dermatology/article/229052/aesthetic-dermatology/more-history-dermatologists-and-skin-care) * * * Hosts: Nick Andrews; Leslie S. Baumann, MD (Skin Type Solutions, Miami) Guest: James J. Leyden, MD (University of Pennsylvania, Philadelphia) Disclosures: Dr. Baumann is CEO of Skin Type Solutions. Dr. Leyden did not report any conflicts of interest. Show notes: Elizabeth Mechcatie * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgeDerm
10/15/20 • 47:36
Dermatology News: Shingrix effective in older adults with preexisting immune-mediated disorders (https://bit.ly/2GrMy7z) New treatment options show promise for centrifugal cicatricial alopecia (https://bit.ly/36Dq2TL) Children's share of new COVID-19 cases is on the rise (https://bit.ly/34CNEoM) * * * Managing a private medical practice has changed drastically in 2020. In this episode, Candrice Heath, MD (@DrCandriceHeath), talks to Caroline Robinson, MD (on Instagram @crobinsonmd; on Twitter @crobinsonmd1), about her experience opening a new dermatology practice during the COVID-19 pandemic. They discuss important safety measures when establishing the office work flow, including offering virtual visits, streamlining patient intake procedures, cleaning examination rooms, and hiring new employees. They also discuss the role of social media in building a successful dermatology practice. “When you think about where people are looking for doctors now ... they’re turning to social more than ever. ... I would say that [half] of the patients that we’ve seen have been either from social media in some way, shape, or form, and then [half] have found me from my previous work within the city,” Dr. Robinson explains. * * * Hosts: Nick Andrews; Candrice R. Heath, MD (Temple University Hospital, Philadelphia) Guests: Caroline Robinson, MD (Tone Dermatology, Chicago) Disclosures: Dr. Heath reports no conflict of interest. Dr. Robinson is the CEO/Founder of Tone Dermatology. Show notes by: Alicia Sonners, Melissa Sears * * * You can find more of our podcasts at http://www.mdedge.com/podcasts Email the show: podcasts@mdedge.com Interact with us on Twitter: @MDedgeDerm
10/8/20 • 36:29